| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.9M | -34.5% | -81.0% |
| R&D Expense | $35.1M | -6.7% | -10.4% |
| SG&A Expense | $31.6M | +10.4% | +54.5% |
| Operating Income | -$61.8M | -5.2% | -83.8% |
| Pre-tax Income | -$55.8M | -5.8% | -117.5% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | -$55.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $79.0M | +26.7% | -51.2% |
| Short-term Investments | $382.4M | -2.1% | -7.3% |
| Current Assets | $472.1M | +1.8% | -19.6% |
| Total Assets | $655.9M | +5.9% | -14.2% |
| Current Liabilities | $118.4M | -2.8% | -13.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$152.1M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | $28.5M | — | — |
| Financing Cash Flow | $96.9M | — | — |
| Free Cash Flow | -$153.6M | — | — |
| -5.7% |
| -115.6% |
| EPS (Basic) | -$0.99 | -5.3% | -106.3% |
| EPS (Diluted) | -$0.99 | -5.3% | -106.3% |
| $215.1M |
| -5.2% |
| -23.7% |
| Stockholders' Equity | $440.8M | +12.4% | -8.7% |